Category - News

Markets

Leerink starts Millendo at OP; PT $24

Leerink Partners launched coverage of Millendo Therapeutics (NASDAQ:MLND) with an “outperform” rating and $24 price target. The stock closed at $9.64 on Dec. 12. Millendo is developing treatments for rare, debilitating...

December 13, 2018

Markets

HCW assumes coverage of Organovo Holdings at buy; PT $2.50

H.C. Wainwright analyst Ed Arce assumed coverage of Organovo Holdings (NASDAQ:ONVO) with a “buy” rating and price target of $2.50. The stock closed at $1.04 on Dec. 12. Organovo was founded in 2007 as a CRO, offering...

December 13, 2018

Markets

AGP starts DarioHealth at buy; PT $2.50

AGP/Alliance Global Partners initiated coverage of DarioHealth (NASDAQ:DRIO) with a “buy” rating and price target of $2.50. The stock closed at 76 cents on Dec. 12. ”DarioHealth is well positioned at the confluence of...

December 13, 2018

Developments

IntelGenx in pact with Gensco Pharma to market RIZAPORT in U.S.

IntelGenx (TSX-V:IGX; OTCQX:IGXT) signed a definitive licensing, development and supply agreement with Gensco Pharma, a specialty pharmaceutical company, for the exclusive commercialization of RIZAPORT in the U.S. “With...

December 12, 2018

Markets

Maxim ups Quantum Genomics PT to €9 from €6

Maxim Group raised its price target for Quantum Genomics SA (Euronext Growth – FR0011648971 – ALQGC) to €9 from €6 after the company held a recent key opinion leader and investor day. The stock closed at €5...

December 12, 2018

Developments

LexaGene completes development of canine UTI syndromic panel

LexaGene Holdings (OTCQB:LXXGF; TSX-V:LXG) has completed development of a syndromic panel to detect urinary tract infection (UTI) in small animals. The assay is capable of detecting each of the eight most common...

December 12, 2018

Markets

Analysts start coverage of Vapotherm at buy; PTs $25, $26

Analysts at Canaccord Genuity and BTIG launched coverage of Vapotherm (NYSE:VAPO) with “buy” ratings and price targets of $25 and $26, respectively. The stock closed at $20.93 on Dec. 7. Vapotherm sells Precision Flow...

December 10, 2018

Markets

Stifel cuts Conatus Pharma to hold; PT to $4 from $10

Stifel downgraded Conatus Pharmaceuticals (NASDAQ:CNAT) to “hold” from “buy” and slashed its price target to $4 from $10 after the company’s ENCORE-PH trial missed its pre-specified primary endpoint. The stock closed at...

December 7, 2018

Developments

Research finds cancer detection in 10-minute blood test

Researchers in Australia have developed a simple blood test they claim can diagnose cancer in 10 minutes by identifying a unique DNA signature present in all types of the disease. While the test has yet to be studied in...

December 6, 2018

Developments

Canopy Growth acquires Storz & Bickel for up to €145-million

Canopy Growth (TSX:WEED; NYSE:CGC) finalized an all-cash transaction to acquire Storz & Bickel GmbH for up to approximately €145-million. Storz & Bickel is widely recognized as the global leader in vaporizer...

December 6, 2018

Category - News

Subscribe